Divi's Lab Share

2023 - 2 - 3

Post cover — Image courtesy of "Economic Times"

Divi's Lab down over 11% as Q3 numbers leave investors ... (Economic Times)

Shares of Divi's Laboratories fell over 11% after the company reported a disappointing set of third quarter numbers. The profit and margins were below ET ...

[Sensex](https://economictimes.indiatimes.com/indices/sensex_30_companies)and [Nifty](https://economictimes.indiatimes.com/indices/nifty_50_companies)Track [latest market news](https://economictimes.indiatimes.com/markets/stocks), [stock tips](https://economictimes.indiatimes.com/markets/stocks/recos)and [expert advice](https://economictimes.indiatimes.com/markets/expert-view)on [ETMarkets](https://economictimes.indiatimes.com/markets). Margins too declined during the third quarter to 23.9%. Total income for the nine-month period came in at Rs 6,099 crore as against Rs 6,503 crore in the corresponding period of previous year. However the chart looks like a bearish Head and Shoulder, indicating substantial more downside. Divi's Labs' net profit dropped 66% to Rs 307 crore for the third quarter as against Rs 902 crore in the same quarter of last year. "I don't track Divis fundamentally.

Divis Labs falls 14%, sinks to 30-month low after a disappointing Q3 (Moneycontrol.com)

Consolidated revenue at Rs 1708 crore was 31.5 percent lower from the year-ago period. The sequential decline in topline was 8 percent.

It has seen a sharp breakout of the long horizontal support trendline adjoining lows of March 19, 2021 and November 14, 2022, indicating nervousness among participants. The operating profit margin came in at 23.90 percent, down more than 2,000 basis points from the year-ago period and falling nearly 1,000 basis points on a sequential basis. On the operating front, EBITDA (earnings before interest, tax, depreciation and amortisation) tanked 63 percent year-on-year to Rs 408.3 crore for the December FY23 quarter and the sequential decline was 34 percent.

Divi's Labs shares tank 13%, hit 52-week low as Q3 net profit falls 66 ... (Livemint)

Divi's Laboratories shares tanked more than 13% to hit a 52-week low level of ₹2796 apiece on the BSE.

Divis Lab sinks 13%, hits 29-mth low as Q3 profit falls more than ... (Business Standard)

Shares of Divis Laboratories tanked 13 per cent to hit a 29-month low of Rs 2,830 on the BSE in Friday's intra-day trade as the company posted weak results ...

The earnings before interest, depreciation, tax and amortization (EBIDTA) was down 63 per cent YoY to Rs 408 crore from Rs 1,097 crore in the year-ago period. Material consumption for this quarter came to be about 43 per cent of sales revenue due to change in product mix, the company said. The company’s consolidated revenue came 31.5 per cent lower to Rs 1,707.68 crore as against analyst’s expectation of around Rs 1,888 crore. In Q3FY23, Divis Labs reported a 66 per cent year-on-year (YoY) decline in its consolidated net profit at Rs 306.80 crore, on higher than expected fall in revenue. In comparison, the S&P BSE Sensex was up 1 per cent at 60,543 at 02:12 pm. Shares of Divis Laboratories tanked 13 per cent to hit a 29-month low of Rs 2,830 on the BSE in Friday’s intra-day trade as the company posted weak results for the December quarter (Q3FY23) disappointing investors.

Divi's Labs misses Q3 profit view; shares plunge over 13 ... (marketscreener.com)

BENGALURU (Reuters) - Indian pharmaceutical firm Divi's Laboratories Ltd on Friday reported a third-quarter profit that widely missed analysts' estimates, ...

The company also makes chemical substances used to make drugs. Divi's makes active pharmaceutical ingredients which are key biologically active elements in a drug that help with the desired health effects. Analysts on an average had expected the company, which makes drug ingredients, to report a profit of 5.33 billion rupees.

Divis Laboratories Ltd posts consolidated Q3FY23 PAT of Rs ... (Equity Bulls)

The Board of Directors of Divis Laboratories Limited, at its meeting held today have approved the financial results of the company for the period ended ...

The stock hit an intraday high of Rs. The total number of shares traded during the day was 234975 in over 35598 trades. ₹2509.86 crs 18.60 for the period ended September 30, 2022. ₹493.60 crs ₹306.80 crs The company has posted net profit / (loss) of Rs. 11.56 for the period ended December 31, 2022 as compared to Rs. ₹1934.62 crs 1934.62 crores during the period ended September 30, 2022. ₹1821.93 crs 1821.93 crores during the period ended December 31, 2022 as compared to Rs.